Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus. (Q40510518)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 2005

Language	Label	Description	Also known as
English	Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.	scientific article published on May 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837213%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837213%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

attenuated vaccine

1 reference

based on heuristic

inferred from title

equine encephalitis

1 reference

based on heuristic

inferred from title

Venezuelan equine encephalitis

1 reference

based on heuristic

inferred from title

Venezuelan equine encephalitis virus

object named as

Venezuelan equine encephalitis virus

1 reference

based on heuristic

inferred from title

Douglas S. Reed

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837213%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Matthew G Lackemeyer

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837213%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Cathleen M Lind

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837213%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Lawrence J Sullivan

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837213%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

William D Pratt

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837213%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Michael D Parker

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837213%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

language of work or name

0 references

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837213%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837213%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837213%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837213%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

3139-3147

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837213%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Phylogenetic analysis of alphaviruses in the Venezuelan equine encephalitis complex and identification of the source of epizootic viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.023

7 January 2021

Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.023

7 January 2021

Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.023

7 January 2021

Attenuated Mutants of Venezuelan Equine Encephalitis Virus Containing Lethal Mutations in the PE2 Cleavage Signal Combined with a Second-Site Suppressor Mutation in E1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.023

7 January 2021

Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.023

7 January 2021

Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.023

7 January 2021

Aerosol infection of cynomolgus macaques with enzootic strains of venezuelan equine encephalitis viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.023

7 January 2021

Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.023

7 January 2021

Discovery and geographic distribution of Venezuelan encephalitis virus in Guatemala, Honduras, and British Honduras during 1965-68, and its possible movement to Central America and México.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.023

7 January 2021

Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.023

7 January 2021

The use of chimeric Venezuelan equine encephalitis viruses as an approach for the molecular identification of natural virulence determinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.023

7 January 2021

Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.023

7 January 2021

Cytotoxic T-cell activity is not detectable in Venezuelan equine encephalitis virus-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.023

7 January 2021

Contribution of T cells to mortality in neurovirulent Sindbis virus encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.023

7 January 2021

The role of antibody in recovery from alphavirus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.023

7 January 2021

Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.023

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40510518&oldid=1733422545"